文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

新型肾脏生物标志物揭示的肾脏生理:ICU生理学应用专辑

What new renal biomarkers tell us about renal physiology: Collection: physiology applied to ICU.
PubMed 文献 · Ann Intensive Care · 2026-01-16
一句话结论新型肾脏生物标志物从肾小球滤过、肾小管应激、损伤、炎症与修复等多维度反映肾脏生理,超越血肌酐和尿量的传统评估。

该综述文章阐述新型肾脏生物标志物如何拓展对肾脏生理的理解。胱抑素C和脑啡肽原较血肌酐更可靠反映肾小球滤过率,几乎不受肌肉量等混杂因素影响。TIMP-2与IGFBP7反映肾小管上皮细胞G1期细胞周期阻滞的早期应激反应,NGAL等反映肾小管损伤,CCL14和CXCL9反映免疫细胞介导的炎症与组织修复。尿液显微镜检查及多参数磁共振成像(mpMRI)可无创评估肾脏灌注、氧合与纤维化,共同提供功能、应激与结构损伤的多维视角,有助于识别AKI特定类型并为干预试验分层患者。

要点

  • 胱抑素C和脑啡肽原作为肾小球滤过率标志物,几乎不受肌肉量等混杂因素影响,较血肌酐提供更可靠的肾功能信息。
  • TIMP-2与IGFBP7通过指示肾小管上皮细胞G1期细胞周期阻滞,揭示对损伤的早期细胞应激反应。
  • NGAL及相关分子提供肾小管损伤和肾脏急性损伤反应的信息。
  • CCL14和CXCL9突出免疫细胞在肾脏炎症和组织修复中的作用。
  • 尿液显微镜检查可提供肾小管细胞健康信息,mpMRI可无创评估肾脏灌注、氧合和纤维化。

研究设计与关键结果

  • 综述文章汇总证据:胱抑素C和脑啡肽原作为肾小球滤过率标志物,几乎不受肌肉量等混杂因素影响,较血肌酐提供更可靠肾功能信息。
  • TIMP-2与IGFBP7通过指示肾小管上皮细胞G1期细胞周期阻滞,揭示对损伤的早期细胞应激反应。
  • NGAL及相关分子提供肾小管损伤和肾脏急性损伤反应的信息。
  • CCL14和CXCL9突出免疫细胞在肾脏炎症和组织修复中的作用,反映肾脏生理的免疫介导方面。
  • 尿液显微镜检查可提供肾小管细胞健康信息;mpMRI可无创评估肾脏灌注、氧合和纤维化,提供空间与功能数据,加深对肾组织动力学及急性损伤向慢性肾脏病进展的理解。
  • 这些生物标志物共同提供肾脏生理的多维视角,区分功能变化、细胞应激反应和结构损伤,有助于识别AKI特定类型并为干预试验分层患者。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

The kidney plays a vital role in maintaining internal homeostasis through waste elimination, electrolyte and acid-base regulation, and endocrine functions. Recent advances in renal biomarkers have expanded our understanding of kidney physiology by providing detailed insights into the complex mechanisms underlying renal function and injury, beyond traditional measures like serum creatinine and urine output. These novel biomarkers reflect distinct physiological processes, including glomerular filtration, tubular cell stress response, tubular cell damage, inflammation and repair processes within the kidney. Markers such as cystatin C and proenkephalin serve as more reliable indicators of glomerular filtration rate (GFR), almost unaffected by confounding factors like muscle mass, thus offering more reliable information about renal function than serum creatinine. Biomarkers including Tissue inhibitor of metalloproteinases-2 and insulin like growth factor binding protein 7 (TIMP-2 and IGFBP7) reveal early cellular responses to stress by indicating G1 cell cycle arrest in tubular epithelial cells, a process intended to provide protection against injury. Neutrophil gelatinase-associated lipocalin (NGAL) and related molecules provide information on tubular damage and the kidney's acute damage responses. Chemokines like C-C motif chemokine ligand 14 (CCL14) and CXCL9 highlight the role of immune cells in kidney inflammation and tissue repair, reflecting immune-mediated aspects of renal physiology. In addition to molecular and cellular biomarkers, urine microscopy can provide insightful information about tubular cell health. Further, advanced imaging techniques such as multiparametric magnetic resonance imaging (mpMRI) enable non-invasive evaluation of renal perfusion, oxygenation, and fibrosis. mpMRI provides spatial and functional data that deepen our understanding of renal tissue dynamics and the progression from acute injury to chronic kidney disease (CKD). Together, these biomarkers offer a multidimensional view of kidney physiology, distinguishing between functional changes, cellular stress responses, and structural injury. By illuminating the diverse biological pathways in both healthy and injured kidneys, they enhance our knowledge of renal pathophysiology, indicate underlying mechanisms, enable the identification of specific types of AKI, and provide opportunities to stratify patients for intervention trials.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Meersch-Dini M, Joannidis M, De Rosa S, et al. What new renal biomarkers tell us about renal physiology: Collection: physiology applied to ICU. Ann Intensive Care. 2026. PMID: 41788482. doi:10.1016/j.aicoj.2025.100017

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。